Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.180
-0.080 (-6.35%)
At close: Jun 27, 2025, 4:00 PM
1.240
+0.060 (5.08%)
After-hours: Jun 27, 2025, 7:57 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $84.90 million as of June 27, 2025. Its market cap has decreased by -88.03% in one year.
Market Cap
84.90M
Enterprise Value
-205.39M
1-Year Change
-88.03%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $84.90M, a decrease of -85.55%. That is a compound annual growth rate of -30.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 84.90M | -60.68% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 259.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.55B |
| Johnson & Johnson | 365.94B |
| AbbVie | 329.73B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.02B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |